Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22%2AOrgan+Transplantation%22&type=Subject&page=10
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22%2AOrgan+Transplantation%22&type=Subject&page=10
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22%2AOrgan+Transplantation%22&type=Subject&page=10
PubPharm (210)
91
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
92
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
93
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
94
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
95
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
96
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
97
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
98
A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
99
Influence of donor IVIG intervention on recipient infection after organ transplantation: a randomized controlled trial. : Influence of donor IVIG intervention on recipient infection after organ transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
100
Influence of donor IVIG intervention on recipient infection after organ transplantation: a randomized controlled trial. : Influence of donor IVIG intervention on recipient infection after organ transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
[1]
« Vorheriger
5
6
7
8
9
10
11
12
13
14
15
Nächster »
[21]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
210
Aufsätze
210
E-Artikel
210
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
210
610
162
Study Type: Interventional
110
Recruitment Status: Not yet recruiting
40
Phase: Phase 2
38
Phase: Phase 3
36
Study Type: Observational
34
Recruitment Status: Authorised-recruitment may ...
30
Phase: Phase 4
28
Recruitment Status: Recruiting
22
Recruitment Status: Completed
16
Medical Condition: Organ Transplantation
12
Medical Condition: CMV infections resistant or ...
10
Phase: Other
8
Medical Condition: Evaluation of the efficacy a...
6
Medical Condition: Immunosuppression after kidn...
6
Phase: Phase 1
6
Recruitment Status: Complete: follow-up complete
6
Study Type: Relative factors research
4
Medical Condition: CMV INFECTIONS IN TRANSPLANT...
4
Medical Condition: Immunosuppression after kidn...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
108
2020-
102
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
208
Englisch
2
Spanisch
Haven't found what you're looking for?
Wird geladen...